Adverse events Not measured · patients with extensor carpi radialis tendinitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events not measured · patients with extensor carpi radialis tendinitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain Visual analog scale Scale from 0 to 100 (lower is better) · patients with extensor carpi radialis tendinitis
1 finding from 1 review
Proportion reporting pain relief of 30% or greater not measured · patients with extensor carpi radialis tendinitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Mortality or tracheostomy at 12 months (pooled hazard ratio)(riluzole 100 mg) · patients with ALS/MND
The intervention showed no clear difference in mortality or tracheostomy at 12 months (pooled hazard… (high certainty).
1 finding from 1 review
Intervention not reported
Per cent mortality at 12 months (riluzole 100 mg) · patients with ALS/MND
The intervention leads to lower per cent mortality at 12 months (riluzole 100 mg) (high certainty).
1 finding from 1 review
Intervention not reported
Rate of decline of Norris Scale ‐ Norris Limb (riluzole 100 mg) · patients with ALS/MND
1 finding from 1 review
Intervention not reported
Rate of decline of Norris Scale ‐ Norris Bulbar (riluzole 100 mg) · patients with ALS/MND
1 finding from 1 review
Intervention not reported
Adverse event: nausea · patients with ALS/MND
The intervention leads to higher adverse event: nausea (high certainty).
1 finding from 1 review
Intervention not reported
Adverse event: asthenia · patients with ALS/MND
The intervention leads to higher adverse event: asthenia (high certainty).
1 finding from 1 review
Intervention not reported
Adverse event: 3‐fold increase in alanine transferase · patients with ALS/MND
The intervention leads to higher adverse event: 3‐fold increase in alanine transferase (high certainty).
1 finding from 1 review